nach oben

Neuropsychology Review

Erschienen in:

07.09.2019 | Review

A Systematic Review of Neurocognitive Functioning in Behçet’s Disease

verfasst von: Caroline A. Fisher, Coco Bernard

Erschienen in: Neuropsychology Review | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Behçet’s disease (BD) is a vascular, inflammatory multisystem disorder with neuro-Behçet’s (NBD) diagnosed in a subset of patients with neurological manifestations. The objective of this review was to determine whether neurocognitive dysfunction is observed in BD, in which neurocognitive domains, and whether there are differences in rates of dysfunction observed between BD and NBD groups. Studies of any methodology were included that reported results from standardized neurocognitive assessment measures in participants with BD or NBD. Twelve group comparison studies met the criteria for inclusion in the review (totalling 284 BD and 157 NBD participants), as well as 17 case study/series papers (11 BD, 35 NBD). Issues with blinding, incomplete data reporting and selective reporting bias were found across the group and case study/series papers, as well as inadequate statistical adjustment for multiple comparisons in the group studies, and the lack of the use of appropriate norms or adjustment for premorbid ability in the case series/studies papers. These quality issues impacted on the conclusions that could be drawn from the current literature. Neurocognitive dysfunction was found in NBD compared to health controls (HC) in a higher proportion of results across studies, than in comparisons between BD and HC groups. The domains in which neurocognitive attenuation was most often reported were visual spatial ability, working memory and acquired knowledge, with more than 25% of these results showing significantly lower functioning in both the BD and NBD groups compared to HC. More than 25% of the processing speed and long-term memory encoding and retrieval results were also lower for the NBD group, compared to HC. Group comparisons between NBD and multiple sclerosis participants indicated few significant differences in neurocognitive test results. The majority of case study/series participants were found to have some degree of attenuated neurocognitive functioning, as defined by case study/series authors.

Al-Dalaan, A. N., al Balaa, S. R., el Ramahi, K., Al-Kawi, Z., Bohlega, S., Bahabri, S., & al Janadi, M. A. (1994). Behçet’s disease in Saudi Arabia. Journal of Rhematology, 21(4), 658–661.

Alibaz-Oner, F., Sawalha, A. H., & Direskeneli, H. (2018). Management of Behçet's disease. Current Opinion in Rheumatology, 30(3), 238–242.PubMedCrossRef

Allott, K., Fisher, C. A., Amminger, G. P., Goodall, J., & Hetrick, S. (2016). Characterizing neurocognitive impairment in young people with major depression: State, trait, or scar? Brain and Behaviour, 6(10), e00527. https://doi.org/10.1002/brb3.527 CrossRef

Arai, T., Mizukami, K., Sasaki, M., Tanaka, Y., Shiraishi, H., Horiguchi, H., et al. (1994). Clinicopathological study on a case of neuro-Behçet’s disease: In special reference to MRI, SPECT and neuropathological findings. The Japanese Journal of Psychiatry and Neurology, 48(1), 77–84.PubMed

Bang, D., Lee, J. H., Lee, E. S., Lee, S., Choi, J. S., Kim, Y. K., ... & Park, S. D. (2001). Epidemiologic and clinical survey of Behçet’s disease in Korea: The first multicenter study. Journal of Korean Medical Science, 16(5), 615–618.

Banich, M. T. (2009). Executive function. The search for an integrated account. Current Directions in Psychological Science, 18(2), 89–94. https://doi.org/10.1111/j.1467-8721.2009.01615.x CrossRef

Beeldman, E., Raaphorst, J., Twennaar, M. K., De Visser, M., Schmand, B. A., & De Haan, R. J. (2016). The cognitive profile of ALS: A systematic review and meta-analysis update. Journal of Neurology, Neurosurgery and Psychiatry, 87(6), 611–619.PubMedCrossRef

Bingol, A., Topcular, B., Yildiz, S., Kaya, P., Tutuncu, M., Demirci, O., ... & Siva, A. (2011). Is Cognitive Dysfunction in Multiple Sclerosis and Neuro-Behçet’s Disease Similar? Paper presented at the Twenty-first Meeting of the European Neurological Society 28–31 May, Lisbon, Portugal. Journal of Neurology, 258(Supplement 1), S102. https://doi.org/10.1007/s00415-011-6026-9

Borson, S. (1982). Behçet’s disease as psychiatric disorder: A case report. American Journal of Psychiatry, 139(10), 1348–1349.PubMedCrossRef

Brown, E. S., & Chandler, P. A. (2001). Mood and cognitive changes during systemic corticosteroid therapy. Primary Care Companion to the Journal of Clinical Psychiatry, 3(1), 17–21.PubMedPubMedCentralCrossRef

Bussone, G., La Mantia, L., Boiardi, A., & Giovannini, P. (1982). Chorea in Behçet’s syndrome. Journal of Neurology, 227(2), 89–92.PubMedCrossRef

Castaneda, A. E., Tuulio-Henriksson, A., Marttunen, M., Suvisaari, J., & Lönnqvist, J. (2008). A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. Journal of Affective Disorders, 106(1), 1–27.PubMedCrossRef

Cavaco, S., Da Silva, A. M., Pinto, P., Coutinho, E., Santos, E., Bettencourt, A., ... & Carvalho, L. (2009). Cognitive functioning in Behçet’s disease. Annals of the New York Academy of Sciences, 1173, 217–26.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum.

Dalvi, S. R., Yildirim, R., & Yazici, Y. (2012). Behçet’s Syndrome. Drugs, 72(17), 2223–2241.PubMedCrossRef

Davatchi, F. (2012). Diagnosis/classification criteria for behcet's disease. Pathology Research International, 2012. https://doi.org/10.1155/2012/607921 CrossRef

Davatchi, F., Assaad-Khalil, S., Calamia, K. T., Crook, J. E., Sadeghi-Abdollahi, B., Schirmer, M., ... & Alekberova, Z. S. (2014). The international criteria for Behçet’s disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. Journal of the European Academy of Dermatology and Venereology, 28(3), 338–347.

Davatchi, F., Chams-Davatchi, C., Ghodsi, Z., Shahram, F., Nadji, A., Shams, H., ... & Sadeghi-Abdolahi, B. (2011). Diagnostic value of Pathergy test in Behçet’s disease according to the change of incidence over the time. Clinical Rheumatology, 30(9), 1151–1155.

Davatchi, F., Shahram, F., Chams-davatchi, C., Shams, H., Nadji, A., Akhlaghi, M., ... & Abdollahi, B. S. (2010). Behçet’s disease in Iran: Analysis of 6500 cases. International Journal of Rheumatic Diseases, 13, 367–373.

Domingos, J., Ferrão, C., Ramalho, J., Rodrigues, T., Moreira, B., Santos, E., ... & Vasconcelos, C. (2015). Characteristics of neuro-Behçet’s disease in a case-series from a single Centre in Northern Portugal. European Neurology, 73(5–6), 321–328.

Dutra, L. A., de Souza, A. W. S., Alessi, H., Guedes, B. D. V. S., Braga-Neto, P., Pedroso, J. L., ... & Barsottini, O. G. P. (2013). Cognitive impairment in Brazilian patients with Behçet’s disease occurs independently of neurologic manifestation. Journal of the Neurological Sciences, 327(1–2), 1–5.

Erberk-Ozen, N., Birol, A., Boratav, C., & Kocak, M. (2006). Executive dysfunctions and depression in Behçet’s disease without explicit neurological involvement. Psychiatry and Clinical Neurosciences, 60, 465–472.PubMedCrossRef

Erkol, G., Vural, M., Karantay, F., & Uluduz, D. (2009). Event-related potentials and paced auditory serial addition test (PASAT) evaluation in Behçet’s syndrome with subclinical neural involvement. Nobel Medicus, 5(2), 29–34.

Evans, V. C., Iverson, G. L., Yatham, L. N., & Lam, R. W. (2014). The relationship between neurocognitive and psychosocial functioning in major depressive disorder: A systematic review. Journal of Clinical Psychiatry, 75(12), 1359–1370.PubMedCrossRef

Farahangiz, S., Sarhadi, S., Safari, A., & Borhani-Haghighi, A. (2012). Magnetic resonance imaging findings and outcome of neuro-Behçet’s disease: The predictive factors. International Journal of Rheumatic Diseases, 15(6), 142–149.CrossRef

Feng, H., Kuo, S., Chen, C., & Yeh, Y. (2014). Nocturnal bruxism in a patient with Behçet disease and posttraumatic stress disorder successfully treated with gabapentin. Clinical Neuropharmacology, 37(6), 190–191.PubMedCrossRef

Fisher, C. A., Sewell, K., & Baker, A. (2016). Chronic behavior disturbance and neurocognitive deficits in neuro-Behçet’s disease: A case study. Neurocase, 22(3), 332–338.PubMedCrossRef

Gabrielyan, I., Harutyunyan, K., Avagyan, G., Amirjanyan, H., Khachaturyan, S., Hambardzumyan, H., & Manvelyan, H. M. (2015). Neuro-Behcet’s disease: A case report. European Journal of Neurology, 22 (Suppl. 1, 510.

Ganzer, F., Bröning, S., Kraft, S., Sack, P. M., & Thomasius, R. (2016). Weighing the evidence: A systematic review on long-term neurocognitive effects of Cannabis use in abstinent adolescents and adults. Neuropsychology Review, 26(2), 186–222.PubMedCrossRef

Gates, N. J., & March, E. G. (2016). A Neuropsychologist’s guide to undertaking a systematic review for publication: Making the Most of PRISMA guidelines. Neuropsychology Review, 26(2), 109–120.PubMedCrossRef

Goodall, J., Fisher, C., Hetrick, S., Phillips, L., Parrish, E. M., & Allott, K. (2018). Neurocognitive functioning in depressed young people: A systematic review and meta-analysis. Neuropsychology Review, 28(2), 216–213. https://doi.org/10.1007/s11065-018-9373-9 CrossRefPubMed

Gündüz, T., Emir, Ö., Kürtüncü, M., Mutlu, M., Tumaç, A., Akca, S., et al. (2012). Cognitive impairment in neuro-Behcet’s disease and multiple sclerosis: A comparative study. International Journal of Neuroscience, 122(11), 650–656. https://doi.org/10.3109/00207454.2012.704454 PubMedCrossRef

Haghighi, A. B., Sarhadi, S., & Farahangiz, S. (2011). MRI findings of neuro-Behçet’s disease. Clinical Rheumatology, 30, 765–770.CrossRef

Hatemi, G., Yazici, Y., & Yazici, H. (2013). Behçet’s Syndrome. Rheumatic Disease Clinics of North America, 39, 245–261.PubMedCrossRef

Hernández, F. J. G., Medina, C. O., Romero, L. M., Román, J. S., Solís, D. G., Franco-Baux, J. R., Merchán, J. M. (2002). Utilidad de La SPECT Cerebral Con HMPAO-99mTc Y de Los Tests Psicométricos En El Diagnóstico de La Afección Neurológica de La Enfermedad de Behçet. Medicina Clinica, 119(12), 446–450.CrossRef

Higgins, J. P. T., Altman, D. C., & Sterne, J. A. C. (2017). Chapter 8: Assessing risk of Bias in included studies. In M. S. Cumpston, J. P. T. Higgins, R. Churchill, & J. Chandler (Eds.), Cochrane handbook for systematic reviews of interventions version 5.2.0 (sections 8:1–8:73). Cochrane (p. 2017).

Hirohata, S., Suda, H., & Hashimoto, T. (1998). Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet’s disease. Journal of the Neurological Sciences, 159(2), 181–185.PubMedCrossRef

Hoelzle, J.B. (2008). Neuropsychological assessment and the Cattell- horn-Carroll (CHC) cognitive abilities model. Theses and Dissertations, 1192, University of Toledo, http://utdr.utoledo.edu/theses-dissertations/1192.

Ideguchi, H., Suda, A., Takeno, M., Kirino, Y., Ihata, A., Ueda, A., ... & Ishigatsubo, Y. (2010). Neurological manifestations of Behçet’s disease in Japan: A study of 54 patients. Journal of Neurology, 257, 1012–1020, https://doi.org/10.1007/s00415-010-5454-2.PubMedCrossRef

International Study Group for Behçet’s Disease. (1990). Criteria for diagnosis of Behçet’s disease. International study Group for Behçet’s disease. Lancet, 335(8697), 1078–1080.

Jewsbury, P. A., & Bowden, S. C. (2017). Construct validity of fluency and implications for the factorial structure of memory. Journal of Psychoeducational Assessment, 35(5), 460–481.CrossRef

Jewsbury, P. A., Bowden, S. C., & Duff, K. (2017). The Cattell–Horn–Carroll model of cognition for clinical assessment. Journal of Psychoeducational Assessment, 35(6), 547–567. https://doi.org/10.1177/0734282916651360 CrossRef

Jewsbury, P. A., Bowden, S. C., & Strauss, M. E. (2016). Integrating the switching, inhibition, and updating model of executive function with the Cattell-horn-Carroll model. Journal of Experimental Psychology: General, 145(2), 220–245.CrossRef

Kale, N., Agaoglu, J., Icen, M., Yazici, I., & Tanik, O. (2008). The presentation of headache in neuro-Behçet’s disease: A case-series. Headache, 49(3), 467–470.CrossRef

Kalra, S., Silman, A., Akman-Demir, G., Bohlega, S., Borhani-Haghighi, A., Constantinescu, C., ... & Siva, A. (2014). Diagnosis and Management of Neuro-Behçet’s disease: International consensus recommendations. Journal of Neurology, 261(9), 1662–1676.

Kawanishi, Y., Hori, T., Suzuki, T., Mizukami, K., Sasaki, M., & Shiraishi, H. (1995). A clinical case of neuro-Behçet syndrome without Mucocutaneo-ocular symptoms: Relationship with brain stem encephalitis. Psychiatry and Clinical Neurosciences, 49(5), 263–266.PubMedCrossRef

Kidd, D. P. (2017). Neurological complications of Behçet’s syndrome. Journal of Neurology, 264(10), 2178–2183.PubMedCrossRef

Kikuchi, H., Sawada, T., Okada, M., Takeno, M., Kuwana, M., Ishigatsubo, Y., ... & Hirohata, S. (2017). Recommendations for the management of neuro-Behçet’s disease by the Japanese national research committee for Behçet’s disease. Journal of the Neurological Sciences, 381, 646–647.

Koçer, N., Islak, C., Siva, A., Saip, S., Akman, C., Kantarci, O., & Hamuryudan, V. (1999). CNS Involvement in Neuro-Behçet Syndrome: An MR Study. American Journal of Neuroradiology, 20(6), 1015–1024.PubMedPubMedCentral

Kronborg, C., Mahar, P. D., & Kelly, R. (2014). Should we keep changing the diagnostic criteria for Behçet’s disease? Dermatology, 228, 1–4.PubMedCrossRef

Larrabee, G. J. (2014). Test validity and performance validity: Considerations in providing a framework for development of an ability-focused neuropsychological test battery. Archives of Clinical Neuropsychology, 29(7), 695–714.PubMedPubMedCentralCrossRef

Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P., ... & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. British Medical Journal, 6(7), e1000100, https://doi.org/10.1136/bmj.b2700 PubMedPubMedCentralCrossRef

Lupien, S. J., Gillin, C. J., & Hauger, R. L. (1999). Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: A dose–response study in humans. Behavioral Neuroscience, 113(3), 420–430.PubMedCrossRef

Madanat, W., Fayyad, F., Verity, D., & Zureikat, H. (2000). Influence of sex on Behçet’s disease in Jordan. In D. Bang, E. Lee, & S. Lee (Eds.), Behçet’s disease (pp. 90–93). Seoul: Design Mecca Publishing.

Mason, R. M., & Barnes, C. G. (1969). Behçet's syndrome with arthritis. Annals of the Rheumatic Diseases, 28(2), 95.PubMedPubMedCentralCrossRef

Matsui, T., Ishida, T., Tono, T., Yoshida, T., Sato, S., & Hirohata, S. (2010). An Attache of cute neuro-Behçet’s disease during the course of chronic progressive neuro-Behçet’s disease: Report of two cases. Modern Rheumatology, 20, 621–626.PubMedCrossRef

Melillo, N., Sangle, S., Stanford, M. R., Andrews, T. C., & D’Cruz, D. P. (2007). Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet’s disease. Clinical Rheumatology., 26(8), 1365–1367. https://doi.org/10.1007/s10067-006-0385-0 CrossRefPubMed

Mimura, M., Kato, M., & Kashima, H. (2009). Neuro-Behcet’s disease presenting with amnesia and frontal dysfunction. Clinical Neurology and Neurosurgery, 111(10), 889–892. https://doi.org/10.1016/j.clineuro.2009.08.002 CrossRefPubMed

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. British Medical Journal, 339(b2535), 332–336.

Monastero, R., Camarda, C., Pipia, C., Lopez, G., Camarda, L. K., Baiamonte, V., ... & Camarda, R. (2004). Cognitive impairment in Behçet’s disease patients without overt neurological involvement. Journal of the Neurological Sciences, 220, 99–104.

Noel, N., Bernard, R., Wechsler, B., Resche-Rigon, M., Depaz, R., Le Thi Huong Boutin, D., ... & Saadoun, D. (2014). Long term outcomes in neuro-Behçet’s disease. Arthritis & Rheumatology, 66(5), 1306–14.

Nurova, B., Kurtuncu, M., Coban, A., Birday, E., & Eraksoy, M. (2014). Computer assisted cognitive rehabilitation in patients with multiple sclerosis and parenchymal neuro-Behçet’s disease. Journal of Neurology, 261(supplement 1), S246.

O'Duffy, J. D., & Goldstein, N. P. (1976). Neurologic involvement in seven patients with Behçet's disease. The American Journal of Medicine, 61(2), 170–178.PubMedCrossRef

Oktem-Tanör, O., Baykan-Kurt, B., Gürvit, I. H., Akman-Demir, G., & Serdaroğlu, P. (1999). Neuropsychological follow-up of 12 patients with neuro-Behçet disease. Journal of Neurology, 246, 113–119. https://doi.org/10.1007/s004150050317 CrossRefPubMed

Özdemir, D. F., Özsoylar, G., Candansayar, S., Coşar, B., & Önder, M. (2004). Psychiatric findings related to neurological complications in Behçet’s disease: A short review and a case presentation. International Journal of Psychiatry in Clinical Practice, 8, 185–190.PubMedCrossRef

Özen, N. E., Birol, A., Boratav, C., & Koçak, M. (2004). Nörolojik Tutulumu Olmayan Behçet Hastalarýnda Biliþsel Bozukluklar. Klinik Psikiyatri, 7, 187–198.

Ozguler, Y., & Hatemi, G. (2016). Management of Behçet's syndrome. Current Opinion in Rheumatology, 28(1), 45–50.PubMedCrossRef

Patten, S. B. (2000). Exogenous corticosteroids and major depression in the general population. Journal of Psychosomatic Research, 49(6), 447–449.PubMedCrossRef

Park, K. W., Seo, J. H., & Yoon, G. U. (2007). Selective anterograde amnesia with thalamus and hippocampal lesions in neuro-Behcet’s disease. Clinical Neurology and Neurosurgery, 109(5), 470–473. https://doi.org/10.1016/j.clineuro.2007.02.016 CrossRefPubMed

Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., ... & Lublin, F. D. (2012). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology, 69(2), 292–302.

Remmers, E. F., Cosan, F., Kirino, Y., Ombrello, M. J., Abaci, N., Satorius, C., ... & Aglar, O. (2010). Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet’s disease. Nature Genetics, 42(8), 698–702.

Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014). Cognitive impairment in depression: A systematic review and meta-analysis. Psychological Medicine, 44(10), 2029–2040.PubMedCrossRef

Ségbédji, K. K. F., Abdulrazak, S., Nubukpo-Guménu, A. A., Benzagmout, M., Aggouri, M., Chakour, K., & Chaoui, M. F. (2017). A fatal case of probable Neurobehcet. Interdisciplinary Neurosurgery: Advanced Techniques and Case Management, 8, 14–16. https://doi.org/10.1016/j.inat.2017.01.008 CrossRef

Shahram, F., Latifi, G., Noroozian, M., Ghadiri, N.K., Abdollahi, B.S., Mohammad, H.F., & Davatchi, F. (2010). 14th International Conference on Behçet’s Disease, London, United Kingdom. In Cognitive Impairment in Patients with Behçet’s Disease: A Case-Control Study, S159. London, United Kingdom.

Shakir, R. A., Sulaiman, K., Kahn, R. A., & Rudwan, M. (1990). Neurological presentation of neuro-Behçet’s syndrome: clinical categories. European Neurology. https://doi.org/10.1159/000117356 PubMedCrossRef

Siva, A., & Saip, S. (2009). The Spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis. Journal of Neurology, 256(4), 513–529.PubMedCrossRef

Soyka, M. (1987). Rezidivierende Verwirrtheitszustande Bei Zerebraler Manifestation Eines Morbus Behçet. Nervenarzt, 58, 388–391.PubMed

Sucullu Karadag, Y., Kurt, P., Sahin, K., Karaaslan, Y., Oztekin, N., & Ak, F. (2014). Cognitive impairment not only in NeuroBehçet but also for all Behçet disease phenotypes. Journal of Neurological Sciences, 31(3), 511–520.

Suda, H. (1999). Low-dose weekly methotrexate therapy for progressive neuro-Behçet’s disease. Japanese Journal of Clinical Immunology, 22(1), 13–22.PubMedCrossRef

Tosto, G., Letteri, F., Canevelli, M., & Bruno, G. (2013). Efficacy of sertraline in a patient with neuro-Beçhet’s disease. Journal of Clinical Neuroscience, 20 (6). Elsevier Ltd: 896–897. https://doi.org/10.1016/j.jocn.2012.05.044.PubMedCrossRef

Topicular, B., Bingol, A., Kaya, P., Yildiz, S., Uluduz, D., Siva, A., & Saip, S. (2011). Cognitive dysfunction in neuro-Behcet’s disease. Journal of Neurology, 258(Suppl 1), S102.

Tsai, K. Y., Chen, J. T., Guo, W. Y., Fuh, J. L., & Liao, K. K. (2001). Behcet’s disease with pathologic laughing and crying: A case report and literature review. Acta Neurologica Taiwanica, 10(4), 271–276.

Tursen, U., Gurler, A., & Boyvat, A. (2006). Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. International Journal of Dermatology, 42, 346–351.CrossRef

Türsen, Ü., & Türsen, B. (2014). Treatment options in Behçet’s disease. Global Journal of Dermatology & Venereology, 2, 27–49.CrossRef

Uǧuz, F., Dursun, R., Kaya, N., & Cilli, A. S. (2007). Quality of life in patients with Behçet’s disease: The impact of major depression. General Hospital Psychiatry, 29, 21–24.PubMedCrossRef

Valesini, G., Pezzi, P. P., Catarinelli, G., Accorinti, M., & Priori, R. (1991). Clinical manifestations of Behçet’s disease in Italy: Study of 155 patients at Rome University. In J. D. O’Duffy & E. Kokmen (Eds.), Behçet’s disease basic and clinical aspects (pp. 279–289). New York: Marcel Decker Inc..

Wada, T., & Takahashi, T. (1969). Psychiatric signs of Behcet’s disease. Nihon Rinsho (Japanese Journal of Clinical Medicine), 27(9), 2328–2332.

Yamada, M., Kashiwamura, K., Nakamura, Y., Ota, T., & Nakamura, K. (1978). On psychiatric symptoms of neuro-Behçet’s syndrome. Folia Psychiatrica et Neurologica Japonica, 32(2), 191–197.PubMed

Zayed, H., Effat, D., Nawito, Z., Abdou, A. A., Nasr El Din, M., El-Refaei, S., … Abu El-Einin, K. (2011). Silent central nervous system involvement in Egyptian Behçet’s disease patients: clinical, psychiatric, and neuroimaging evaluation. Clinical Rheumatology, 30, 1173–1180.PubMedCrossRef

Zuliani, C., Boni, P., & Fattorello, C. (1998). Valutazione Neuropsicologica in Un Caso Di Neuro-Behcet. Rivista Medica, 4(1), 67–70.

Titel: A Systematic Review of Neurocognitive Functioning in Behçet’s Disease
verfasst von: Caroline A. Fisher
Coco Bernard
Publikationsdatum: 07.09.2019
Verlag: Springer US
Erschienen in: Neuropsychology Review / Ausgabe 4/2019
Print ISSN: 1040-7308
Elektronische ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-019-09416-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Caregiver- and Clinician-Reported Adaptive Functioning in Rett Syndrome: a Systematic Review and Evaluation of Measurement Strategies

Visuospatial Neglect - a Theory-Informed Overview of Current and Emerging Strategies and a Systematic Review on the Therapeutic Use of Non-invasive Brain Stimulation

Towards a Better Understanding of Cognitive Deficits in Absence Epilepsy: a Systematic Review and Meta-Analysis

To Watch is to Work: a Review of NeuroImaging Data on Tool Use Observation Network

A Guide to Conducting a Meta-Analysis with Non-Independent Effect Sizes